Equity · Healthcare
ALKS
Alkermes plc · NasdaqGS
The line runs $37.00 on 20 May through $49.86 on 17 August, on a scale from $30 to $60. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ALKS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $37.00 on 20 May 2026 through $49.86 on 17 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026
ALKS insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 21 compensation filings in this window. The figures above count all of them.
ALKS reported financials
ALKS reported revenue of $1.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $241.7M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
ALKS earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ALKS institutional holders
12 of the 45 institutional funds we track reported a ALKS position for the quarter ended 30 Jun 2026 — a combined $1.2B; the latest of those filings landed 14 Aug 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
ALKS fails-to-deliver
On 29 Jul 2026, 20 shares of ALKS failed to deliver (about $1K).
Source: SEC fails-to-deliver (CNS) data